1、1Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement,make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in relia
2、nce upon the whole or any part of the contents of this announcement.Hospital Corporation of China Limited弘和仁愛醫療集團有限公司(Incorporated in the Cayman Islands with limited liability)(Stock Code:3869)ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31,2020 AND PROPOSED APPOINTMENT OF NON-EXECUTIVE DI
3、RECTORAND MEMBER OF REMUNERATION COMMITTEEThe board(the“Board”)of directors(the“Directors”)of Hospital Corporation of China Limited(the“Company”)is pleased to announce the audited consolidated results of the Company and its subsidiaries(collectively,the“Group”or“we”)for the year ended December 31,20
4、20(the“year under review”),together with the comparative figures in 2019.2FINANCIAL HIGHLIGHTSAs at December 31,20202019RMB000RMB000Revenue399,214410,883Gross profit margin48.7%42.3%Adjusted gross profit margin(1)56.6%50.5%(Loss)/profit for the year(3)(421,069)169,446Adjusted profit for the year(2)1
5、34,371121,680Basic(losses)/earnings per share(in RMB)(2.926)1.092Adjusted itemsExpenses of share-based awards and other one-off employee benefit expenses(2)(i)2,6623,264Amortization of identifiable intangible assets identified in acquisitions(2)(iii)28,77430,500Gains/(losses)on fair value change res
6、ulting from value change of convertible bonds and foreign exchange gains/(losses)and net gains resulting from convertible bonds extension(2)(ii)100,43294,096Investing and financing related expenses(2)(iv)6,50012,566Total amount of impairment losses on intangible assets and the reversal of deferred i